retatrutide weight loss clinical trial results Eli Lilly infiltrates anti-obesity market as Phase III for begins VisualAbstract: Retatrutide reduces body weight

Combining genetic insights with clinical biomarkersfasting glucose, HbA1c, lipid paneland your symptom timeline can support a more informed conversation with your provider about whether microdosing, standard dosing, or other GLP-1 formulations best align with your health goals and tolerability profile

Schlumberger M, Pacini F, Wiersinga WM, Toft A, Smit JW, Sanchez Franco F, Lind P, Limbert E, Jarzab B, Jamar F, Duntas L, Cohen O, Berg G

Im now the same size as I was in my early 20s

The first few months, particularly the 'Month 3 of GLP-1' mark, were a period of significant adjustment and initial results

Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, and Melchionda N: Metformin in non-alcoholic steatohepatitis

These structural changes greatly increase the GLP-1 like peptide's half life (t 1/2 = 1 week) compared to endogenous GLP-1 (t 1/2 = 2 minutes)